Marco Ruella

52PUBLICATIONS
339CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Aug 10, 2026
Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

|May 15, 2026
Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy.

|Apr 29, 2026
Spatial atlas of diabetic kidney disease reveals a B cell-rich subgroup.

|Mar 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Gregory M Chen, Ankita Jain, David T Gering

|Feb 06, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Zhiwei Ang, Annette Castro, Luca Paruzzo

|Feb 04, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

Pageof 9

Frequent Collaborators

17 joint publications

Luca Paruzzo

13 joint publications

Carl H June

12 joint publications

Stephen J Schuster

8 joint publications

Joseph A Fraietta